Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NIH
NIH
Molecular Partners' Covid-19 therapy proves inactiv
EP Vantage
Tue, 11/16/21 - 11:54 am
Molecular Partners
COVID-19
clinical trials
NIH
Moderna, escalating dispute with NIH, claims government had no role in key vaccine patent
BioPharma Dive
Thu, 11/11/21 - 11:40 pm
Moderna Therapeutics
vaccines
NIH
patents
COVID-19
Moderna squares off with US government over COVID jab patent
Pharmaforum
Wed, 11/10/21 - 09:44 pm
Moderna Therapeutics
NIH
patents
COVID-19
vaccines
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
FDA
Wed, 10/27/21 - 11:49 pm
Bespoke Gene Therapy Consortium
NIH
FDA
gene therapy
Why Shares of Cassava Sciences Rose 15% Today
Motley Fool
Thu, 09/23/21 - 10:48 pm
Cassava Sciences
Alzheimer's disease
simufilam
NIH
NIH launches study into COVID-19 vaccine booster among people with autoimmune disease
Biopharma Reporter
Wed, 09/1/21 - 11:04 am
NIH
autoimmune disease
clinical trials
COVID-19
vaccines
boosters
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
NIH
Wed, 04/21/21 - 10:31 am
NIH
clinical trials
drug repurposing
COVID-19
Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81%
Endpoints
Mon, 04/12/21 - 11:09 am
Regeneron
monoclonal antibodies
NIH
COVID-19
U.S. begins study on allergic reaction risk in Moderna, Pfizer vaccines
Yahoo/Reuters
Wed, 04/7/21 - 10:28 am
NIH
Pfizer
BioNTech
Moderna Therapeutics
allergic reactions
vaccines
COVID-19
clinical trials
Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data
Fierce Pharma
Fri, 04/2/21 - 10:55 am
Regeneron
FDA
Eylea
diabetic retinopathy
NIH
Is a 'super-seasonal' flu vaccine on the horizon? The NIH and UW are taking a shot into the clinic this April
Endpoints
Thu, 03/25/21 - 11:20 am
vaccines
universal flu vaccine
NIH
University of Washington
AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions
MedCity News
Tue, 03/23/21 - 10:46 am
AstraZeneca
NIH
vaccines
COVID-19
Brii Bio joins the NIH graveyard alongside GSK, Lilly after flopping antibody study in hospitalized Covid-19 patients
Endpoints
Fri, 03/5/21 - 10:47 am
Brii Biosciences
NIH
antibodies
COVID-19
AI-designed serotonin tracker could help develop neurology drugs
Pharmaforum
Sat, 12/26/20 - 08:19 pm
NIH
serotonin
neurology
artificial intelligence
NIH Is Planning A Study To Find Out What’s Causing Allergic Reactions To Pfizer’s Covid-19 Vaccine
Forbes
Mon, 12/21/20 - 11:36 pm
NIH
CDC
allergic reaction
anaphylaxis
vaccines
Pfizer
BioNTech
COVID-19
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
Endpoints
Thu, 12/17/20 - 06:25 pm
GSK
Vir Biotechnology
Eli Lilly
antibodies
NIH
COVID-19
clinical trials
Study: ECMO ‘significantly’ improves heart attack patients’ survival
Mass Device
Mon, 11/16/20 - 10:15 am
NIH
ECMO
heart attacks
devices
Coronavirus vaccine trial leader Larry Corey on the tough FDA, policy decisions to come
BioPharma Dive
Tue, 10/20/20 - 10:55 am
vaccines
FDA
NIH
Moderna Therapeutics
COVID-19
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Pharmaforum
Fri, 10/9/20 - 10:52 am
Eli Lilly
olumiant
baricitinib
Gilead Sciences
Veklury
remdesivir
COVID-19
clinical trials
NIH
AstraZeneca's COVID-19 vaccine adverse event has NIH 'very concerned'
Fierce Biotech
Wed, 09/16/20 - 10:57 am
NIH
vaccines
clinical trials
COVID-19
AstraZeneca
AZD1222
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »